OptiBiotix Health PLC (OPTI)
Industry Biotechnology
This stock can be held in an Investment ISA, SIPP and Investment Account
Sell
18.00p
Buy
19.00p
-0.75p (-3.90%)
OptiBiotix Health PLC is a life sciences company. The company through its subsidiaries is engaged in the research and development of microbiome modulators.
Prices updated at 09 May 2025, 17:05 BST
| Prices minimum 15 mins delay
|
Prices in GBX
Important documents: Please ensure that you have read the Pre-sale Illustrations document & Doing Business with Fidelity document (incorporating the Fidelity Client Terms) and
- Key stats
- Price
- Fair value
- Dividends
- News
- Financials
- Valuation
- Profile
Sector
Healthcare
Industry
Biotechnology
Chairman
Mr. Richard Colin Neil Davidson CBE
CEO
Mr. Stephen Patrick O'Hara
Most recent earnings
31 Dec 2023
Fiscal year end
31 Dec 2023
Employees
5
Head office
Innovation Centre, Innovation Way
York
United Kingdom
YO10 5DG
Key personnel
Owner name | Salary | Bonus | All other compensation | Total compensation | Restricted stock award |
---|---|---|---|---|---|
Mr. Richard Colin Neil Davidson CBE Non-Executive Director, Chairman | - | - | - | - | - |
Mr. Michael Sean Christie Non-Executive Director | - | - | - | - | - |
Dr. Sofia Kolyda Executive Director, Research and Development | - | - | - | - | - |
Mr. Stephen Patrick O'Hara Executive Director, Chief Executive Officer | - | - | - | - | - |
Top 5 shareholders
Owner name | No. of shares | Share as % of port. | Last change | Portfolio % change | Date of portfolio | % Total assets |
---|---|---|---|---|---|---|
No data |
Director dealings
Date | Action | Name | Price | Value | No. of shares | Holding (%) | Additional info |
---|---|---|---|---|---|---|---|
No data |
Please note that past performance is not a reliable indicator of future returns.